Welspun Enterprises Limited informed the Exchange about the Statement of Deviation and variation Report for the quarter ended September 30, 2026

WEL/SEC/2026 November 05, 2026 BSE Limited National Stock Exchange of India Limited Scrip Code: 532553 NSE Symbol: WELENT Dear Madam / Sir, Sub: Statement of deviation or variation for the quarter ended September 30, 2026 Ref: Funds raised by issuance of convertible warrants by way of preferential issue on a private placement basis Pursuant to Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with SEBI Mater Circular No. HO/49/14/14(7)2025-CFD- POD2/I/3762/2026 dated January 30, 2026, we hereby confirm that during the quarter ended September 30, 2026, there was no deviation or variation in the utilisation of proceeds of convertible warrants. In this regard, a statement of deviation or variation for the quarter ended September 30, 2026, duly reviewed by the Audit Committee and the Board of Directors of the Company at their respective meetings held today, i.e. November 05, 2026, is enclosed herewith as “Annexure-A”. The above information is also available on the Company’s website at www.welspunenterprises.com We request you to take the above on record. Thanking you. Yours faithfully, For Welspun Enterprises Limited Nidhi Tanna Company Secretary ACS-30465 Encl.: As above Annexure-A Name of listed entity Welspun Enterprises Limited Mode of Fund Raising Public Issues/ Right Issues / Preferential Issue/ QIP / Others Date of Fund Raising October 15, 2025 Amount Raised (Rs. in Crore) Rs. 1,000* Report filed for Quarter ended September 30, 2026 Monitoring Agency Applicable Monitoring Agency Name, if applicable CRISIL Ratings Limited Is there a Deviation / Variation in use of No funds raised If yes, whether the same is pursuant to Not Applicable change in terms of a contract or objects, which was approved by the shareholders If yes, Date of shareholder approval Not Applicable Explanation for the Deviation/ Not Applicable Variation Comments of the Audit Committee None Comments of the auditors, if any None Objects for which funds have been raised and where there has been a deviation, in the following table Original Object Modified Original Modified Funds Amount of Remarks Object, if Allocation allocation, Utilised Deviation / if any any (Rs. In if any (Rs. (Rs. In Variation for Crores) In Crores) Crores) the quarter according to applicable object Infusion of funds for No 750.00* N.A. 250.00 Nil Nil Construction of 6-Lane Partially Elevated Highway Corridor along with improvement of existing road from Km. 10+600 to Km. 64+000 (Section Pune to Shirur of NH-753F – Minimum Design Length 53.40 Km) in the State of Maharashtra on DFBOT (Toll) Mode, with concession period of 29 years pursuant to receipt of Letter of Award either directly or through SPV (to be incorporated upon receipt of Letter of Award) General Corporate Purposes No 250.00* N.A. N.A. Nil Nil Total 1,000.00* Note 1: As on September 30, 2026, the Company had received 25% of the issue size, aggregating to ₹250 Crore, as upfront consideration/subscription amount calculated at ₹131.25 per warrant for 1,90,47,619 warrants. The balance 75% of the issue size, amounting to ₹750 Crore (i.e., ₹393.75 per warrant), shall be received upon exercise of the conversion option by the warrant holders for conversion of warrants into equity shares within a period of 18 months from the date of allotment of warrants. During the quarter ended September 30, 2026, the Company has fully utilized the ₹250 Crore received towards the stated objects of the issue. Accordingly, as on September 30, 2026, there was no unutilized amount remaining out of the upfront consideration/subscription amount received. *All figures are rounded off to two decimal places.